New Drug for Rare Neuroendocrine Tumors Shows Durable Activity

(MedPage Today) — BERLIN — Belzutifan (Welireg) induced durable responses in advanced pheochromocytoma or paraganglioma (PPGL) in a single-arm phase II trial, evidence that supported FDA’s recent approval in these very rare neuroendocrine tumors…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118019

Author :

Publish date : 2025-10-18 21:17:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

New Drug for Rare Neuroendocrine Tumors Shows Durable Activity

How Many Young Adults Used Cannabis or Alcohol to Help Sleep?

Shingles Vaccination Tied to Drops in Cardiovascular Events, Dementia, Death

Related Posts

New Antiobesity Drugs Eagerly Anticipated

Doctors Have a Front-Row Seat to the Caregiver Crisis

Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids

Standard-of-Care Treatment for Rheumatoid Arthritis Lags for Minority Groups

Cardiologist Heads New ACIP; Distal Access Catheter Recall; Another Lipid Marker?

New Antiobesity Drugs Eagerly Anticipated

Doctors Have a Front-Row Seat to the Caregiver Crisis

Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids

Standard-of-Care Treatment for Rheumatoid Arthritis Lags for Minority Groups

Cardiologist Heads New ACIP; Distal Access Catheter Recall; Another Lipid Marker?

Delaying Hep B Vaccine in Infants Carries Significant Risks, Report Warns

Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

Categories

Archives